PortfoliosLab logoPortfoliosLab logo
GRMN vs. CME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GRMN vs. CME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Garmin Ltd. (GRMN) and CME Group Inc. (CME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GRMN achieves a 16.41% return, which is significantly higher than CME's -5.50% return. Over the past 10 years, GRMN has outperformed CME with an annualized return of 21.88%, while CME has yielded a comparatively lower 14.50% annualized return.


GRMN

1D
-0.57%
1M
-2.02%
YTD
16.41%
6M
17.82%
1Y
15.26%
3Y*
33.20%
5Y*
13.00%
10Y*
21.88%

CME

1D
-2.09%
1M
-10.39%
YTD
-5.50%
6M
-4.13%
1Y
-4.58%
3Y*
15.54%
5Y*
7.50%
10Y*
14.50%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GRMN vs. CME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GRMN
Garmin Ltd.
16.41%-0.06%63.25%43.12%-30.20%15.90%25.86%58.13%9.84%27.60%
CME
CME Group Inc.
-5.50%19.83%15.41%31.32%-22.89%29.47%-6.34%9.67%32.15%32.35%

Correlation

The correlation between GRMN and CME is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Dec 6, 2002

0.27

The correlation between GRMN and CME shifts across timeframes, from -0.04 (1 year) to 0.27 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GRMN:

$45.53B

CME:

$91.54B

EPS

GRMN:

$8.97

CME:

$11.75

PE Ratio

GRMN:

26.23

CME:

21.45

PEG Ratio

GRMN:

2.11

CME:

1.87

PS Ratio

GRMN:

6.10

CME:

13.46

PB Ratio

GRMN:

4.91

CME:

3.44

Total Revenue (TTM)

GRMN:

$7.46B

CME:

$6.76B

Gross Profit (TTM)

GRMN:

$4.41B

CME:

$5.84B

EBITDA (TTM)

GRMN:

$2.26B

CME:

$5.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GRMN vs. CME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GRMN
GRMN Risk / Return Rank: 5555
Overall Rank
GRMN Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
GRMN Sortino Ratio Rank: 5252
Sortino Ratio Rank
GRMN Omega Ratio Rank: 5454
Omega Ratio Rank
GRMN Calmar Ratio Rank: 5555
Calmar Ratio Rank
GRMN Martin Ratio Rank: 5555
Martin Ratio Rank

CME
CME Risk / Return Rank: 3030
Overall Rank
CME Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
CME Sortino Ratio Rank: 2727
Sortino Ratio Rank
CME Omega Ratio Rank: 2727
Omega Ratio Rank
CME Calmar Ratio Rank: 3535
Calmar Ratio Rank
CME Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GRMN vs. CME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Garmin Ltd. (GRMN) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GRMNCMEDifference
Sharpe ratioReturn per unit of total volatility

+0.74

Sortino ratioReturn per unit of downside risk

+1.03

Omega ratioGain probability vs. loss probability

1.12

0.98

+0.14

Calmar ratioReturn relative to maximum drawdown

0.55

-0.21

+0.76

Martin ratioReturn relative to average drawdown

1.20

-0.72

+1.93

GRMN vs. CME - Sharpe Ratio Comparison

The current GRMN Sharpe Ratio is 0.51, which is higher than the CME Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of GRMN and CME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GRMNCMEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.51

-0.23

+0.74

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.43

0.38

+0.05

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.78

0.61

+0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

0.45

0.59

-0.14

Drawdowns

GRMN vs. CME - Drawdown Comparison

The maximum GRMN drawdown since its inception was -87.71%, which is greater than CME's maximum drawdown of -77.50%. Use the drawdown chart below to compare losses from any high point for GRMN and CME.


Loading charts...

Drawdown Indicators


GRMNCMEDifference

Max Drawdown

Largest peak-to-trough decline

-87.71%

-77.50%

-10.21%

Max Drawdown (1Y)

Largest decline over 1 year

-27.97%

-21.42%

-6.55%

Max Drawdown (3Y)

Largest decline over 3 years

-27.97%

-21.42%

-6.55%

Max Drawdown (5Y)

Largest decline over 5 years

-54.63%

-31.74%

-22.89%

Max Drawdown (10Y)

Largest decline over 10 years

-54.63%

-37.36%

-17.27%

Current Drawdown

Current decline from peak

-12.07%

-20.95%

+8.88%

Average Drawdown

Average peak-to-trough decline

-31.53%

-20.69%

-10.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.71%

6.35%

+6.36%

Volatility

GRMN vs. CME - Volatility Comparison

The current volatility for Garmin Ltd. (GRMN) is 7.87%, while CME Group Inc. (CME) has a volatility of 10.21%. This indicates that GRMN experiences smaller price fluctuations and is considered to be less risky than CME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GRMNCMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.87%

10.21%

-2.34%

Volatility (6M)

Calculated over the trailing 6-month period

22.18%

16.89%

+5.29%

Volatility (1Y)

Calculated over the trailing 1-year period

30.12%

20.38%

+9.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.38%

20.06%

+10.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.34%

23.89%

+4.45%

Dividends

GRMN vs. CME - Dividend Comparison

GRMN's dividend yield for the trailing twelve months is around 1.53%, less than CME's 4.44% yield.


PositionTTM20252024202320222021202020192018201720162015
CME
CME Group Inc.
4.44%1.83%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%
GRMN
Garmin Ltd.
1.53%1.70%1.44%2.27%3.10%1.92%2.01%2.30%3.32%3.42%4.21%5.41%

Financials

GRMN vs. CME - Financials Comparison

This section allows you to compare key financial metrics between Garmin Ltd. and CME Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B1.20B1.40B1.60B1.80B2.00B2.20B20222023202420252026
1.75B
1.88B
(GRMN) Total Revenue
(CME) Total Revenue
Values in USD except per share items

GRMN vs. CME - Profitability Comparison

The chart below illustrates the profitability comparison between Garmin Ltd. and CME Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%75.0%80.0%85.0%90.0%20222023202420252026
59.4%
88.1%
Portfolio components
GRMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Garmin Ltd. reported a gross profit of 1.04B and revenue of 1.75B. Therefore, the gross margin over that period was 59.4%.

CME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.

GRMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Garmin Ltd. reported an operating income of 431.67M and revenue of 1.75B, resulting in an operating margin of 24.6%.

CME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.

GRMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Garmin Ltd. reported a net income of 405.08M and revenue of 1.75B, resulting in a net margin of 23.1%.

CME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.


Frequently Asked Questions


GRMN and CME have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CME has higher volatility (10.21%) compared to GRMN (7.87%). In terms of maximum drawdown, GRMN dropped -87.71% vs CME's -77.50%.

GRMN currently has the higher Sharpe Ratio (0.51 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GRMN and CME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer